PhaseRx, Inc.
Other OTCTotal Valuation
PhaseRx, Inc. carries a market capitalization of 1,169.00, placing it among publicly traded companies globally. Its enterprise value stands at 9.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1,169.00 |
| Enterprise Value | 9.77M |
Share Statistics
PhaseRx, Inc. currently has 11.69M shares outstanding.
| Shares Outstanding | 11.69M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.12 |
| P/TBV Ratio | -31.85 |
| P/FCF Ratio | -0.75 |
| P/OCF Ratio | -0.75 |
Financial Position
PhaseRx, Inc. maintains a current ratio of 2.14, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,807.64, indicating conservative leverage, while an interest coverage ratio of -13.74 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.14 |
| Quick Ratio | 1.93 |
| Debt / Equity | -1,807.64 |
| Debt / EBITDA | -0.42 |
| Interest Coverage | -13.74 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -109.45 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Income Statement
EBITDA reached -12.95M, while operating income came in at -13.04M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -13.04M |
| Pretax Income | -13.89M |
| Net Income | -13.89M |
| EBITDA | -12.95M |
| EBIT | -13.04M |
| Earnings Per Share (EPS) | -1.19 |
Balance Sheet
PhaseRx, Inc. holds 5.26M in cash and equivalents against 5.44M in total debt, resulting in a net debt position of 184,000.00. Total book value stands at -80.00M, with working capital of 3.10M providing operational flexibility.
| Cash & Cash Equivalents | 5.26M |
| Total Debt | 5.44M |
| Net Debt | 184,000.00 |
| Equity (Book Value) | -80.00M |
| Book Value Per Share | -6.84 |
| Working Capital | 3.10M |
Cash Flow
PhaseRx, Inc. produced -12.82M in operating cash flow over the past twelve months. After subtracting -14,000.00 in capital expenditures, free cash flow totaled -12.83M - equivalent to -1.10 per share.
| Operating Cash Flow | -12.82M |
| Capital Expenditures | -14,000.00 |
| Free Cash Flow | -12.83M |
| FCF Per Share | -1.10 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 5.55 |
| FCF Yield | -133.60 |
Scores
PhaseRx, Inc. posts an Altman Z-Score of -24.15, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -24.15 |